±±Ê¦´óϸ°ûÉúÎïѧ£º e
1ts/@V
Ò»¡¢ Ãû´Ê½âÊÍ£º 5yBaxw`
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© ,t?c=u\5
2£® PCR£¨96£© f"i(+:la
3£® ·ºËØ£¨ubquitin£©£¨96£© /6S% h-#\
4£® °é·Ö×Ó£¨chapron£©£¨96£© WRIOj Q:
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© dZ^(e0& :H
6£® DG£IP3£¨96£© ye?4^@u u
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© "wwAbU<
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© =T7lv%u
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© 3%HF" $Gg
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© Yvmo%.oU
11£® Transformation£¨92£© (S<Z@y+d
12£® TransfectionתȾ£¨92£© ly_@dsU'
13£® TranscytosisתÒÆ×÷Óã¨92£© Z:_ wE62'
14£® Transductionתµ¼£¨92£© cl\Gh
15£® Transdetermination£¨92£© ,EsPm'`?A/
16£® Transdifferentiation£¨92£© U-h'a:
K
17£® Transgenic animalת»ùÒò¶¯Î92£© KkD.n#A
18£® Rb£1£¨92£© 3jeB\
19£® P53£¨92¡¢91£© KH=4A-e,0
20£® C£jun£¨92£©
PeU>h2t
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© =@ SJyW
22£® °ûÄÚÌ壨99£© $RASpM
23£® Cyclin dependent kinase inhibitor(CDKI)(99) X6h@K</c^:
24£® G£protein£¨91£©
WRdBL5
25£® Restriction point£¨91£© <t~RGn3
26£® Antipost£¨91£© O\~/J/u
<
27£® Capping£¨91£© D6Q6yNE
28£® TATAbox£¨91£© heizO",8.&
29£® cDNA library£¨90£© dx.,
30£® Aritotic apparatus£¨90£© Ng Jp2ut
31£® ¿çĤÐźŠtransmembrane signal£¨90£© Gl!fT1zh0
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© T> < Vw
33£® Nuclear lamina£¨90£© II,snRD
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£© BdM
meM2h
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© $T#yxx
36£® ϸ°û·Ö»¯£¨00£© *m>XtBw.
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© M= ]]kJ:I
38£® ¿Ë¡£¨00£© LK>J]p
39£® »ùÒò×飨00£© {e/6iSpT
40£® Caspase£¨00£© hRc.^"q9
41£® ת¼Òò×Ó£¨00£© Sd9%tO9mf
42£® ÅßÌ¥¸Éϸ°û£¨01£© U%PII>s'#
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© 3Yb2p!o
44£® DNAоƬ£¨01£© th4yuDPuA
¶þ¡¢ ÎÊ´ðÌ⣺ Zqp<8M2
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© 8T]x4JQ0
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æ书ÄÜ£¨95£© n[f<]4<
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© _+0QQ{'N
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© yG/_k!{9
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© 2D vKW%;
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© wI{ED
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© <\6<-x(H5
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© tR{@NFUcu
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© _oU}>5
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿Øϸ°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© 4UV6'X)V
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷Íƶ¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© \J?l7mG
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© }
N$soaUs
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£© YT@D*\
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© Dpf"H
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹Øϵ£¨95£© .$s>b#m O
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£© `9>1 w d
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æ书ÄÜ£¨93£© s.{n
xk.
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£© M#'j7EMu
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© 2sXNVo8`w"
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æ䶨λ¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© ),%(A~\
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäÄ¿Ç°ËùÖªµÄ¹¦ÄÜ£¨01£© P)k!#*
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖصãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£© sSdnH_;&
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© 3mCf>qj73
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£©
.^ o3
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© ,T<q"d7-#
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆڵĵ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© Q[Xh{B
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹Øϵ£¨91£© 65g"$:0
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© 8
mFy9{M
29£® ÊÔÊöºáÎƼ¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© tpQ?E<O
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æ书ÄÜ£¨95£© =TcT` ](o
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£© NJqjW
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© BK/~2u
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£© *l9Wj$vja
34£® ¾ÙÀý˵Ã÷ÃâÒßÓ«¹âFISH¡¢ÃâÒߵ羵ÖîÏî¼¼ÊõµÄ»ù±¾ÔÀí¼°ÆäÔÚϸ°ûÉúÎïѧÑо¿Öеĸ÷½â¾öʲôÎÊÌ⣨94£© L3s1a -K
35£® ÄãµÄ˶ʿÂÛÎÄÌá³öÁËʲôÎÊÌ⣿ÈçºÎ½â¾öµÄ£¿½áÂÛÊÇʲô£¿£¨96¡¢94¡¢00£©